Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

Author:

Jinnah H.A.,Comella Cynthia L.,Perlmutter JoelORCID,Lungu CodrinORCID,Hallett Mark

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

National Institute of Neurological Disorders and Stroke

Allergan Inc.

Merz Pharmaceuticals

Beat Dystonia

The Benign Essential Blepharospasm Foundation

Cure Dystonia Now

Dystonia Inc.

Dystonia Ireland

The Dystonia Medical Research Foundation

The European Dystonia Federation

The Foundation for Dystonia Research

The National Spasmodic Dysphonia Association

The National Spasmodic Torticollis Association

Tyler's Hope for a Dystonia Cure

NIH

Ipsen Inc.

Benign Essential Blepharospasm Research Foundation

Dystonia Medical Research Foundation

Lesch-Nyhan Syndrome Children's Research Foundation

Ipsen Biopharmaceuticals, Inc

Merz Pharmaceutical

Biotie Inc

Cambridge

Humana Press

Wolters Kluwer

Parkinson's Disease Foundation

NINDS

NCATS

NIA

NIEHS

American Parkinson Disease Association

Greater St. Louis Chapter of the APDA

Barnes-Jewish Hospital Foundation

Elliot Stein Family Fund

he Parkinson Disease Research Fund

Oertli Fund

CHDI

Michael J. Fox Foundation

Barbara and Sam Murphy Fund

Huntington Disease Society of America

Neurotoxin Institute

Cambridge University Press

Oxford University Press

Elsevier

UniQure

Publisher

Elsevier BV

Subject

Toxicology

Reference42 articles.

1. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement;Albanese;J. Neurol.,2015

2. Therapeutic advances in dystonia;Albanese;Mov. Disord.,2015

3. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia;Berman;Mov. Disord.,2005

4. Psychiatric associations of adult-onset focal dystonia phentypes;Berman;J. Neurol. Neurosurg. Psychiat.,2017

5. Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A;Brashear;Mov. Disord.,2000

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3